Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX15 | P16050 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | SAT1 | P21673 | 1/20 | 0.35 |
| ▸ | CA12 | O43570 | 2/20 | 0.34 |
| ▸ | CA1 | P00915 | 2/20 | 0.34 |
| ▸ | CA2 | P00918 | 2/20 | 0.34 |
| ▸ | CA9 | Q16790 | 2/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23928730 | 0.95 | ALOX15 (0.41) | ALOX15MEN1CYP1A2KMT2ASMN1; SMN2 | |
| SCHEMBL4267249 | 0.87 | LPAR3 (0.42) | ALOX15MEN1CYP1A2KMT2ASMN1; SMN2 | |
| SCHEMBL4264382 | 0.81 | LPAR3 (0.46) | ALOX15MEN1CYP1A2KMT2ASMN1; SMN2 | |
| SCHEMBL4275598 | 0.80 | LPAR3 (0.48) | ALOX15MEN1CYP1A2KMT2ASMN1; SMN2 | |
| SCHEMBL4264879 | 0.80 | LPAR3 (0.48) | ALOX15MEN1CYP1A2KMT2ASMN1; SMN2 | |
| SCHEMBL4273613 | 0.75 | LPAR2 (0.39) | ALOX15MEN1CYP1A2KMT2ASMN1; SMN2 | |
| SCHEMBL1427269 | 0.74 | — | — | |
| Guanidine SCHEMBL28990996 | 0.73 | CYP3A4 (0.50) | TSHR | |
| Phosphoric Acid SCHEMBL28436026 | 0.72 | ALOX15 (0.43) | ALOX15MEN1CYP1A2KMT2ASMN1; SMN2 | |
| Phosphoric Acid SCHEMBL29118306 | 0.72 | ALOX15 (0.43) | ALOX15MEN1CYP1A2KMT2ASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4731765-A2 | COMPOSITIONS AND METHODS TO MODULATE TUMOR MICROENVIRONMENT ASSOCIATED LONG NONCODING RNAS | Haya Therapeutics SA (CH) | 2026-04-29 | — | — | EP | disclosed |
| WO-2025056973-A9 | COMPOSITIONS AND METHODS FOR MODULATING WISP2 SUPER-ENHANCER-ASSOCIATED RNA | HAYA THERAPEUTICS SA (CH) | 2025-04-10 | — | — | WO | disclosed |
| WO-2025056973-A2 | COMPOSITIONS AND METHODS FOR MODULATING WISP2 SUPER-ENHANCER-ASSOCIATED RNA | HAYA THERAPEUTICS SA (CH) | 2025-03-20 | — | — | WO | disclosed |
| CN-119452094-A | Aptamer discovery and selection techniques | 因美纳有限公司 | 2025-02-14 | — | — | CN | disclosed |
| WO-2024261531-A2 | COMPOSITIONS AND METHODS TO MODULATE TUMOR MICROENVIRONMENT ASSOCIATED LONG NONCODING RNAS | HAYA THERAPEUTICS SA (CH) | 2024-12-26 | — | — | WO | disclosed |
| EP-4466074-A1 | POLY-TAILED AND POLY-CAPPED MRNA AND USES THEREOF | The Broad Institute Inc. (US) | 2024-11-27 | — | — | EP | disclosed |
| EP-4314332-A2 | METHODS FOR IDENTIFICATION AND RATIO DETERMINATION OF RNA SPECIES IN MULTIVALENT RNA COMPOSITIONS | ModernaTX, Inc. (US) | 2024-02-07 | — | — | EP | disclosed |
| WO-2023141474-A9 | POLY-TAILED AND POLY-CAPPED MRNA AND USES THEREOF | THE BROAD INSTITUTE, INC. (US) | 2023-10-26 | — | — | WO | disclosed |
| WO-2023141474-A1 | POLY-TAILED AND POLY-CAPPED MRNA AND USES THEREOF | THE BROAD INSTITUTE, INC. (US) | 2023-07-27 | — | — | WO | disclosed |
| WO-2022212711-A2 | METHODS FOR IDENTIFICATION AND RATIO DETERMINATION OF RNA SPECIES IN MULTIVALENT RNA COMPOSITIONS | MODERNATX, INC. (US) | 2022-10-06 | — | — | WO | disclosed |